Depression in cancer patients: A critical review

Clinical Practice and Epidemiology in Mental Health

Volumn 3, Issue , 2007, Pages

  Pasquini, Massimo ^a,b   Biondi, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYDROCORTISONE; INTERLEUKIN 6; OMEGA 3 FATTY ACID; PLACEBO; PROLACTIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTICHOLINERGIC EFFECT; ATTITUDE TO DEATH; BEHAVIOR THERAPY; BODY IMAGE; CANCER PATIENT; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CORRELATION ANALYSIS; DEPRESSION; DISEASE COURSE; EMOTIONAL STRESS; FEAR; HEALTH CARE COST; HEALTH CARE NEED; HUMAN; LIFE EVENT; LIFESTYLE; MEDICAL RESEARCH; MENTAL HEALTH CARE; MENTAL STRESS; PATIENT COMPLIANCE; PERSONAL EXPERIENCE; PREVALENCE; PROGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; SELF ESTEEM; SIDE EFFECT; SOCIAL INTERACTION; TREATMENT PLANNING; VOMITING;

EID: 33847237249     PISSN: 17450179     EISSN: None     Source Type: Journal    
DOI: 10.1186/1745-0179-3-2     Document Type: Review

References (95)

1. US Mortality Public Use Data Tape 2001, National Center for Health Statistics, Centers for Disease Control and Prevention 2003
2. WHO International Consortium in Psychiatric Epidemiology. Cross-national comparisons of prevalences and correlates of mental disorders Bulletin of World Health Organization 2000 78 413-26
3. Üstün TB The global Burden of mental health disorders American Journal of Public Health 1999 89 1315-1318 1508755 10474545
4. Grassi L Rosti G Psychiatric and psychosocial concomitants of abnormal illness behaviour in patients with cancer Psychother Psychosom 1999 65 246-252
5. Sharpe M Strong V Allen K Rush R Postma K Tulloh A Maguire P House A Ramirez A Cull A Major depression in outpatients attending a regional cancer centre: Screening and unmet treatment needs Br J Cancer 2004 90 2 314-20 10.1038/sj.bjc.6601578 14735170
6. Prieto JM Atala J Blanch J Carreras E Rovira M Cirera E Espinal A Gasto C Role of Depression as a predictor of mortality among cancer patients after stem-cell transplantation J Clin Oncol 2005 23 6063-6071 10.1200/ JCO.2005.05.751 16087949
7. Coyne JC Palmer SC Shapiro PJ Thompson R De ichele A Distress, psychiatric morbidity, and prescriptions for psychotropic medication in breast cancer waiting room sample Gen Hosp Psychiatry 2004 26 121-128 10.1016/j.genhosppsych.2003.08.012 15038929
8. Ell K Sanchez K Vourlekis B Lee PJ Dwight-Johnson M Lagomasino I Muderspach L Russell C Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer J Clin Oncol 2005 23 3052-3060 1460295 15860863 10.1200/ JCO.2005.08.041
9. Okamura M Yamawaki S Akechi T Taniguchi K Uchitomi Y Psychiatric disorders following breast cancer recurrence: Prevalence, associated factors and relationship to quality of life Jpn J Clin Oncol 2002 35 6 302-309 10.1093/jjco/hyi097
10. Burgess C Cornelius V Love S Graham J Richards M Ramirez A Depression and anxiety in women with early breast cancer: Five year observational cohort study BMJ 2005 330 702-707 555631 15695497 10.1136/ bmj.38343.670868.D3
11. Zabora J Blanchard CG Smith ED Prevalence of psychological distress among cancer patients across the disease continuum J Psychosoc Oncol 1997 15 73-87 10.1300/J077V15N02_05
12. Kadan-Lottick NS Vanderwerker LC Block SD Zhang B Prigerson HG Psychiatric disorders and mental health service use in patients with advanced cancer Cancer 2005 104 12 2872-81 1459283 16284994 10.1002/ cncr.21532
13. Korfage IJ Essink-Bot ML Janssens AC Schroder FH de Koning HJ Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up Br J Cancer 2006 94 8 1093-8 10.1038/sj.bjc.6603057 16622434
14. Bardwell WA Natarajan L Dimsdale JE Rock CL Mortimer JE Hollenbach K Pierce JP Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer J Clin Oncol 2006 24 16 2420-7 10.1200/JCO.2005.02.0081 16651649
15. Berard RMF Depression and anxiety in oncology: The Psychiatrist's perspective J Clin Psychiatry 2001 62 8 58-61 12108824
16. Ashbury FD Madlensky L Raich P Thompson M Whitney G Hotz K Kralj B Edell WS Antidepressant prescribing in community cancer care Support Care Cancer 2003 11 278-285 12720073
17. Bailey RK Geyen DJ Scott-Gurnell K Hipolito MMS Bailey TA Beal JM Understanding and treating depression among cancer patients Int J Gynecol Cancer 2005 15 203-208 10.1111/j.1525-1438.2005.15204.x 15823100
18. Derogatis LR Melisaraatos N The Brief Symptom inventory (BSI): An introductory report Psychol Med 1983 13 595-606 6622612
19. Zigmond AS Snaith RP The Hospital Anxiety and Depression Scale Acta Psychiatr Scand 1983 67 361-70 6880820
20. Radloff LS The CES-D: A self-report depression scale for research in the general population Appl Psychol Meas 1977 3 385-401
21. Beck AT Ward C Reliability of psychiatric diagnoses. A study of clinical judgements and ratings Am J Psychiatry 1962 19 351-356
22. American Psychiatric Association Diagnostic and statistical manual of mental disorders Washington DC: American Psychiatric Association 4 1994
23. Raison C Miller A Depression in cancer: New developments regarding diagnosis and treatment Biol Psychiatry 2003 54 283-294 10.1016/ S0006-3223(03)00413-X 12893104
24. Keller M Sommerfeldt S Fischer C Knight L Riesbeck M Lowe B Herfarth C Lehnert T Recognition of distress and psychiatric morbidity in cancer patients: A multi-method approach Annals of Oncology 2004 15 1243-1249 10.1093/annonc/mdh318 15277265
25. Costantini M Musso M Viterbori P Bonci F Del Mastro L Garrone O Venturini M Morasso G Detecting psychological distress in cancer patients: Validity of the Italian version of the Hospital Anxiety and Depression Scale Support Care Cancer 1999 7 121-127 10.1007/ s005200050241 10335929
26. Biondi M Picardi A Pasquini M Gaetano P Pancheri P Dimensional psychopathology of depression: Detection of an "activation" dimension in unipolar depressed oupatients Journal of Affective Disorders 2005 84 133-139 10.1016/S0165-0327(02)00103-9 15708410
27. Pasquini M Picardi A Biondi M Gaetano P Morosini P Relevance of Anger and Irritability in Outpatients with Major Depressive Disorder Psychopathology 2004 37 155-160 10.1159/000079418 15237244
28. Feinstein AR An additional science for clinical medicine. The development of clinimetrics Ann Intern Med 1983 99 843-848 6651026
29. Fava GA Ruini C Rafanelli C Psychometric Theory Is an Obstacle to the Progress of Clinical Research Psychother Psychosom 2004 73 145-148 10.1159/000076451 15031586
30. Brennan J Adjustment to cancer-coping or personal transition? Psycho-Oncology 2001 10 1-18 10.1002/1099-1611(200101/ 02)10:1<1::AID-PON484>3.0.CO;2-T 11180573
31. Servaes P Verhagen C Bleijenberg G Fatigue in cancer patients and after treatment: Prevalence, correlates and interventions Eur J Cancer 2002 38 27-43 10.1016/S0959-8049(01)00332-X 11750837
32. Portenoy RK Itri LM Cancer-related fatigue: Guidelines for evaluation and management Oncologist 1999 4 1-10 10337366
33. Stone P Richards M A'Hern R Hardy J A study to investigate the prevalence, severity, and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer Ann Oncol 2000 11 561-567 10.1023/A:1008331230608 10907949
34. Morrow GR Hickok JT Roscoe JA Raubertas RF Andrews PL Flynn PJ Hynes HE Banerjee TK Kirshner JJ King DK University of Rochester Cancer Center Community Clinical Oncology Program Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program J Clin Oncol 2003 21 4635-41 10.1200/JCO.2003.04.070 14673053
35. Bower JE Ganz PA Dickerson SS Petersen L Aziz N Fahey JL Diurnal cortisol rhythm and fatigue in breast cancer survivors Psychoneuroendocrinology 2005 30 92-100 10.1016/j.psyneuen.2004.06.003 15358446
36. Dantzer R Somatization: A psychoneuroimmune perspective Psychoneuroendocrinology 2005 30 947-952 10.1016/j.psyneuen.2005.03.011 15949897
37. Surveillance, Epidemiology, and End Results Program, 1975-2000, Division of Cancer Control and Population Sciences, National Cancer Institute 2003
38. Touitou Y Levi F Bogdan A Benavides M Bailleul F Misset JL Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors J Cancer Res Clin Oncol 1995 121 181-188 10.1007/BF01198101 7713990
39. Touitou Y Bogdan A Levi F Benavides M Auzeby A Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens Br J Cancer 1996 74 248-1252
40. Porter LS Mishel M Neelon V Belyea M Pisano E Soo MS Cortisol levels and responses to mammography screening in breast cancer survivors: A pilot study Psychosom Med 2003 65 5 842-848 10.1097/01.PSY.0000088595.91705.C5 14508030
41. Abercrombie HC Janine Giese-Davi J Sephton S Epel ES Turner-Cobb JM Spiegel D Flattened cortisol rhythms in metastatic breast cancer patients Psychoneuroendocrinology 2004 29 1082-1092 10.1016/ j.psyneuen.2003.11.003 15219660
42. Sephton S Sapolsky R Kraemer H Spiegel D Diurnal cortisol rhythm as a predictor of breast cancer survival J Natl Cancer Inst 2000 92 994-1000 10.1093/jnci/92.12.994 10861311
43. Osborne RH Sali A Aaronson NK Elsworth GR Mdzewski B Sinclair AJ Immune function and adjustment style: Do they predict survival in breast cancer? Psycho-Oncology 2004 13 199-210 10.1002/pon.723 15022155
44. Vedhara K Stra JT Miles JN Sanderman R Ranchor AV Psychosocial factors associated with indices of cortisol production in women with breast cancer and controls Psychoneuroendocrinology 2006 31 3 299-311 10.1016/ j.psyneuen.2005.08.006 16183206
45. Turner-Cobb JM Sephton SE Koopman C Blake-Mortimer J Spiegel D Social support and salivary cortisol in women with metastatic breast cancer Psychosom Med 2000 2 337-345
46. Kobayakawa M Yamawaki S Hamazaki K Akechi T Inagaki M Uchitomi Y Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer Br J Cancer 2005 93 12 1329-33 10.1038/sj.bjc.6602877 16306875
47. Adler A Stein JA Ben-Efraim S Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease Cancer 1980 45 2074-2083 10.1002/ 1097-0142(19800415)45:8<2074::AID-CNCR2820450814>3.0.CO;2-K 7370953
48. Levy SM Herberman RB Lippman M D'Angelo T Lee J Immunological and psychosocial predictors of disease recurrence in patients with early stage breast cancer Behav Med 1991 17 67-75 1878611
49. Reiche EM Morimoto HK Nunes SM Stress and depression-induced immune dysfunction: Implications for the development and progression of cancer Int Rev Psychiatry 2005 6 515-27 10.1080/02646830500382102 16401550
50. Reiche EM Nunes SO Morimoto HK Stress, depression, the immune system, and cancer Lancet Oncol 2004 5 10 617-625 10.1016/S1470-2045(04)01597-9 15465465
51. Andersen BL Farrar WB Golden-Kreutz D Kutz LA MacCallum R Courtney ME Glaser R Stress and immune response after surgical treatment for regional breast cancer J Natl Cancer Inst 1998 90 30-36 10.1093/jnci/ 90.1.30 9428780
52. Penedo FJ Dahn JR Kinsinger D Antoni MH Molton I Gonzalez JS Fletcher MA Roos B Carver CS Schneiderman N Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer J Psychosom Res 2006 60 4 423-7 10.1016/j.jpsychores.2005.08.001 16581368
53. Fawzy FI Kemeny ME Fawzy NW Elashoff R Morton D Cousins N Fahey JL A structured psychiatric intervention for cancer patients, II: Changes over time in immunological measures Arch Gen Psychiatry 1990 47 729-735 2143062
54. Musselman DL Miller AH Porter MR Manatunga A Gao F Penna S Pearce BD Landry J Glover S McDaniel JS Nemeroff CB Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings Am J Psychiatry 2001 158 1252-1257 10.1176/ appi.ajp.158.8.1252 11481159
55. Jehn CF Kuehnhardt D Bartholomae A Pfeiffer S Krebs M Regierer AC Schmid P Possinger K Flath BC Biomarkers of depression in cancer patients Cancer 2006 17036362
56. Costanzo ES Lutgendorf SK Sood AK Anderson B Sorosky J Lubaroff DM Psychosocial factors and interleukin-6 among women with advanced ovarian cancer Cancer 2005 15, 104 2 305-13 10.1002/cncr.21147
57. Raison CL Miller AH Depression in Cancer: New Developments Regarding Diagnosis and Treatment Biol Psychiatry 2003 54 283-294 10.1016/ S0006-3223(03)00413-X 12893104
58. Hammacher A Thompson EW Williams ED Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer Int J Biochem Cell Biol 2005 37 2 442-50 10.1016/ j.biocel.2004.07.011 15474988
59. George DJ Halabi S Shepard TF Sanford B Vogelzang NJ Small EJ Kantoff PW The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480 Clin Cancer Res 2005 11 5 1815-20 10.1158/ 1078-0432.CCR-04-1560 15756004
60. Jee SH Chu CY Chiu HC Huang YL Tsai WL Liao YH Kuo ML Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways Invest Dermatol 2004 123 6 1169-75 10.1111/j.0022-202X.2004.23497.x
61. Cools-Lartigue J Marshall JC Caissie AL Saraiva VS Burnier MN Jr Secretion of interleukin-6 and prostaglandin E2 during uveal melanoma-monocyte in vitro interactions Exp Eye Res 2004 79 4 451-4 10.1016/j.exer.2004.05.015 15381029
62. Berger FG The interleukin-6 gene: A susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality Breast Cancer Res Treat 2004 88 3 28- 5 10.1007/s10549-004-0726-0 15609131
63. Savard J Simard S Ivers H Morin CM Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects J Clin Oncol 2005 1;23 25 6083-96 10.1200/JCO.2005.09.548
64. Matsuoka Y Yamawaki S Inagaki M Akechi T Uchitomi Y A Volumetric Study of Amygdala in Cancer Survivors with Intrusive Recollections Biol Psychiatry 2003 54 736-743 10.1016/S0006-3223(02)01907-8 14512214
65. Yoshikawa E Matsuoka Y Yamasue H Inagaki M Nakano T Akechi T Kobayakawa M Fujimori M Nakaya N Akizuki N Imoto S Murakami K Kasai K Uchitomi Y Prefrontal cortex and amygdala volume in first minor or major depressive episode after cancer diagnosis Biol Psychiatry 2006 59 8 707-12 10.1016/ j.biopsych.2005.08.018 16213471
66. Inagaki M Yoshikawa E Kobayakawa M Matsuoka Y Sugawara Y Nakano T Akizuki N Fujimori M Akechi T Kinoshita T Furuse J Murakami K Uchitomi Y Regional cerebral glucose metabolism in patients with secondary depressive episodes after fatal pancreatic cancer diagnosis J Affect Disord 2006, Sep 19 16989906
67. Kumano H Ida I Oshima A Takahashi K Yuuki N Amanuma M Oriuchi N Endo K Matsuda H Mikuni M Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients. A preliminary PET study J Psychiatr Res 2006, May 8 16684544
68. Watson M Homewood J Haviland J Bliss JM Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort Eur J Cancer 2005 41 12 1710-4 10.1016/ j.ejca.2005.01.012 16098457
69. Onitilo AA Nietert PJ Egede LE Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site Gen Hosp Psychiatry 2006 28 5 396-402 10.1016/j.genhosppsych.2006.05.006 16950374
70. Faller H Bülzebruck H Drings P Lang H Coping, distress and survival among patients with lung cancer Arch Gen psychiatry 1999 56 756-762 10.1001/archpsyc.56.8.756 10435611
71. Butow PN Coates AS Dunn SM Psychosocial predictors of survival in metastatic melanoma J Clin Oncol 1999 17 2256-2263 10561283
72. Butow PN Coates AS Dunn SM Psychosocial predictors of survival: metastatic breast cancer Ann Oncol 2000 11 469-474 10.1023/ A:1008396330433 10847468
73. Spiegel D Giese-Davis J Depression and cancer: Mechanisms and disease progression Biol Psychiatry 2003 54 269-282 10.1016/ S0006-3223(03)00566-3 12893103
74. Fawzy FI Canada AL Fawzy NW Malignant melanoma: Effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up Arch Gen Psychiatry 2003 60 100-103 12511177
75. Palmer SC Coyne JC Examining the Evidence that Psychotherapy Improves the Survival of Cancer Patients Biol Psychiatry 2004 56 61-64 10.1016/ j.biopsych.2004.02.028 15219474
76. Dwight-Johnson M Ell K Lee PJ Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study Psychosomatics 2005 46 3 224-32 10.1176/ appi.psy.46.3.224 15883143
77. Peveler R House A Developing services in liaison psychiatry: Making the case of need Liaison Psychiatry. Planning Services for Specialist Settings Glasgow; Gaskell Peveler R, Feldman E, Friedman T 2000 1-14
78. Williams S Dale J The effectiveness of treatment for depression/ depressive symptoms in adults with cancer: A systematic review Br J Cancer 94 3 372-90 2006 Feb 13 10.1038/sj.bjc.6602949 16465173
79. Fisch M Treatment of Depression in Cancer Journal of the National Cancer Institute Monographs 2004 32 105-111 10.1093/jncimonographs/lgh011 15263050
80. Loprinzi CL Pisansky TM Fonseca R Sloan JA Zahasky KM Quella SK Novotny PJ Rummans TA Dumesic DA Perez EA Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors J Clin Oncol 1998 16 7 2377-2381 9667254
81. Tasmut T Hartel B Kalso E Venlafaxine in neuropathic pain following treatment of breast cancer Eur J Pain 2002 6 17-24 10.1053/ eujp.2001.0266 11888224
82. Kimmick GG Lovato J McQuellon R Robinson E Muss HB Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen Breast J 2006 12 2 114-22 10.1111/ j.1075-122X.2006.00218.x 16509835
83. Durand JP Brezault C Goldwasser F Protection against oxaliplatin acute neurosensory toxicity by venlafaxine Anticancer Drugs 2003 14 6 423-425 10.1097/00001813-200307000-00006 12853883
84. Razavi D Allilaire J Smith M Salimpour A Verra M Desclaux B Saltel P Piollet I Gauvain-Piquard A Trichard C Cordier B Fresco R Guillibert E Sechter D Orth JP Bouhassira M Mesters P Blin P The effect of fluoxetine on anxiety and depression symptoms in cancer patients Acta Psychiatr Scand 1996 94 205-210 8891089
85. Theobald DE Kirsh KL Holtsclaw E Donaghy K Passik SD An Open-Label, Crossover Trial of Mirtazapine (15 and 30 mg) in Cancer Patients with Pain and Other Distressing Symptoms J Pain Symptom Manage 2002 23 5 442-7 10.1016/S0885-3924(02)00381-0 12007762
86. Richards S Umbreit JN Fanucchi MP Giblin J Khuri F Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan South Med Journal 2003 96 10 1031-3 10.1097/01.SMJ.0000084311.35864.D6
87. Thompson DS Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology Psychosomatics 2000 41 4 356-9 10.1176/ appi.psy.41.4.356 10906359
88. Davis MP Khawam E Pozuelo L Lagman R Management of symptoms associated with advanced cancer: Olanzapine and mirtazapine a World Health Organization project Expert Rev Anticancer Ther 2002 2 4 365-376 10.1586/ 14737140.2.4.365 12647979
89. Pasquini M Biondi M Costantini A Cairoli F Ferrarese G Picardi A Sternberg C Detection and treatment of depressive and anxiety disorders among cancer patients: Feasibility and preliminary findings from a liaison service in an Oncology Division' Depression and Anxiety 2006 16 1-8
90. Stiefel F Die Trill M Berney A Nunez Olatre JM Razavi D Depression in palliative care: A pragmatic report from the Expert working Group of The European Association for Palliative Care Support Care Cancer 2001 9 477-488 10.1007/s005200100244 11680829
91. Newell SA Sanson-Fisher RW Savolainen NJ Systematic review of psychological therapies for cancer patients: Overview and recommendations for the future J Natl Cancer Inst 2002 94 558-584 11959890
92. Sheard T Maguire P The effect of psychological interventions on anxiety and depression in cancer patients results of two meta-analyses British Journal of Cancer 1999 80 11 1770-1780 10.1038/sj.bjc.6690596 10468295
93. Meyer TJ Mark MM Effect of psychosocial interventions with adult cancer patients: A meta-analysis of randomized experiments Health Psychology 1995 14 2 101-108 10.1037/0278-6133.14.2.101 7789344
94. Passik SD Dugan W McDonald MV Rosenfeld B Theobald DE Egerton S Oncologist's recognition of depression in their patients with cancer J Clin Oncol 1998 16 1594-1600 9552071
95. Boscaglia N Clarke DM Jobling TW Quinn MA The contribution of spirituality and spiritual coping to anxiety and depression in women with a recent diagnosis of gynecological cancer Int J Gynecol Cancer 2005 15 5 755-61 10.1111/j.1525-1438.2005.00248.x 16174220